159 related articles for article (PubMed ID: 32372156)
1. Oct4 expression in gastric carcinoma: association with tumor proliferation, angiogenesis and survival.
El-Guindy DM; Wasfy RE; Abdel Ghafar MT; Ali DA; Elkady AM
J Egypt Natl Canc Inst; 2019 Nov; 31(1):3. PubMed ID: 32372156
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of HMGA2 and Oct4 predicts an unfavorable prognosis in human gastric cancer.
Kong D; Su G; Zha L; Zhang H; Xiang J; Xu W; Tang Y; Wang Z
Med Oncol; 2014 Aug; 31(8):130. PubMed ID: 25037576
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of putative markers of cancer stem cells in gastric cancer: A retrospective cohort study.
Chen XL; Chen XZ; Wang YG; He D; Lu ZH; Liu K; Zhang WH; Wang W; Li CC; Xue L; Zhao LY; Yang K; Liu JP; Zhou ZG; Hu JK; Mo XM
Oncotarget; 2016 Sep; 7(38):62049-62069. PubMed ID: 27557490
[TBL] [Abstract][Full Text] [Related]
4. Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer.
Li N; Deng W; Ma J; Wei B; Guo K; Shen W; Zhang Y; Luo S
Med Oncol; 2015 Jan; 32(1):433. PubMed ID: 25491144
[TBL] [Abstract][Full Text] [Related]
5. Oct4, a novel marker for human gastric cancer.
Chen Z; Xu WR; Qian H; Zhu W; Bu XF; Wang S; Yan YM; Mao F; Gu HB; Cao HL; Xu XJ
J Surg Oncol; 2009 Jun; 99(7):414-9. PubMed ID: 19347886
[TBL] [Abstract][Full Text] [Related]
6. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
7. [OCT4 expression in hepatocellular carcinoma and its clinical significance].
Huang PZ; Lu CL; Li BK; Hong J; Huang L; Wang L; Zhang Y; Yuan YF
Chin J Cancer; 2010 Jan; 29(1):111-16. PubMed ID: 20038322
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of NOTCH1 and OCT4 in gastric carcinoma.
Ibrahim DA; Elsebai EA; Fayed A; Abdelrahman AE
Indian J Pathol Microbiol; 2022; 65(2):328-335. PubMed ID: 35435367
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of octamer-binding transcription factor 4 in patients with gastric cancer: a systematic review and meta-analysis.
Wei Y; Liu H; Wang C; Zhang W; Wen X; Long H; Xu Z; Guo H; Liu Y; Wei D; Qiu C; Li G; Sun Z
Biomark Med; 2019 Feb; 13(3):219-234. PubMed ID: 30810340
[TBL] [Abstract][Full Text] [Related]
10. Association of High Expression Levels of SOX2, NANOG, and OCT4 in Gastric Cancer Tumor Tissues with Progression and Poor Prognosis.
Basati G; Mohammadpour H; Emami Razavi A
J Gastrointest Cancer; 2020 Mar; 51(1):41-47. PubMed ID: 30628031
[TBL] [Abstract][Full Text] [Related]
11. LAPTM4B-35, a cancer-related gene, is associated with poor prognosis in TNM stages I-III gastric cancer patients.
Cheng X; Zheng Z; Bu Z; Wu X; Zhang L; Xing X; Wang X; Hu Y; Du H; Li L; Li S; Zhou R; Wen XZ; Ji JF
PLoS One; 2015; 10(4):e0121559. PubMed ID: 25849595
[TBL] [Abstract][Full Text] [Related]
12. SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Liu Y; Luo X; Deng J; Pan Y; Zhang L; Liang H
Tumour Biol; 2015 Apr; 36(4):2685-94. PubMed ID: 25472580
[TBL] [Abstract][Full Text] [Related]
13. Down regulation of RNA binding motif, single-stranded interacting protein 3, along with up regulation of nuclear HIF1A correlates with poor prognosis in patients with gastric cancer.
Wu Y; Yun D; Zhao Y; Wang Y; Sun R; Yan Q; Zhang S; Lu M; Zhang Z; Lu D; Li Y
Oncotarget; 2017 Jan; 8(1):1262-1277. PubMed ID: 27902480
[TBL] [Abstract][Full Text] [Related]
14. Expression of thymidine phosphorylase in human gastric carcinoma.
Takebayashi Y; Miyadera K; Akiyama S; Hokita S; Yamada K; Akiba S; Yamada Y; Sumizawa T; Aikou T
Jpn J Cancer Res; 1996 Mar; 87(3):288-95. PubMed ID: 8613432
[TBL] [Abstract][Full Text] [Related]
15. High Oct4 predicted worse prognosis of right-sided colon cancer patients.
Wang QH; Zhang M; Shi CT; Xie JJ; Chen F; Shi QF; Cheng J; Wang HN
Future Oncol; 2018 Sep; 14(22):2279-2291. PubMed ID: 29656661
[TBL] [Abstract][Full Text] [Related]
16. [Expression of OCT4 in gastric cancer cell lines and its significance].
Huang ZJ; Wang R; Luo WY; Yi WC; Zeng YY; Luo Q
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):812-5. PubMed ID: 23387203
[TBL] [Abstract][Full Text] [Related]
17. Relative Expression of OCT4, SOX2 and NANOG in Oral Squamous Cell Carcinoma Versus Adjacent Non- Tumor Tissue.
Baghai Naini F; Aminishakib P; Abdollahi A; Hodjat M; Mohammadpour H; Kardouni Khoozestani N
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1649-1654. PubMed ID: 31244283
[TBL] [Abstract][Full Text] [Related]
18. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
19. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
20. OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor.
Asadi MH; Mowla SJ; Fathi F; Aleyasin A; Asadzadeh J; Atlasi Y
Int J Cancer; 2011 Jun; 128(11):2645-52. PubMed ID: 20824712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]